site stats

Laurikka-routti

Web1 Jun 1992 · M. Laurikka-Routti, M. Haukkamaa, O. Heikinheimo. A contraceptive ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry. Contraception, 42 (1990), pp. 111-120. View PDF View article View in Scopus Google Scholar. 12. WebMarjut Laurikka-Routti, Maija Haukkamaa, Pekka Lähteenmäki. Department of Obstetrics and Gynecology; Research output: Contribution to journal › Article › Scientific › peer-review. Overview; Original language: English: Journal: Fertility and Sterility : official journal of the American Fertility Society : Volume: 58: Pages (from-to)

Suppression of ovarian-function with the transdermally given …

WebM Laurikka-Routti 1 , M Haukkamaa, O Heikinheimo. Affiliation 1 Department of Medical Chemistry, University of Helsinki, Finland. PMID: 2387151 DOI: 10.1016/0010 … WebPIP: Physicians inserted a new 4-cm subdermal implant releasing the progestin ST-1435 (78 mg) into the ventral area of the left upper arm in 26 healthy 20-36 year old women at the … money heist cz dabing https://gradiam.com

Subdermal progestin implant (Nestorone) in the treatment of ...

Web1 Sep 1994 · M Laurikka-Routti Serum lipids, blood pressure, body weight and serum chemistry in women using subcutaneous contraceptive implants releasing the progestin … Web1 Dec 1992 · Laurikka-Routti, M. Haukkamaa, O. Heikinheimo, A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipid and serum chemistry Contraception 42: (1990) 111-120 13. Web1 Oct 1992 · M. Laurikka-Routti, M. Haukkamaa, O. Heikinheimo A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry Contraception, 42 ( 1990), pp. 111 - 120 View PDF View article View in Scopus Google Scholar 10. icd 10 code for accessory bone foot

A contraceptive subdermal implant releasing the progestin ST …

Category:Suppression of ovarian function with the ... - Semantic Scholar

Tags:Laurikka-routti

Laurikka-routti

Pharmacokinetics and bioavailability of ST 1435 administered by ...

WebMarjut Laurikka-Routti. LKT, naistentautien ja synnytysten erikoislääkäri. Customer rating 9.7. An average from 24 months, when above 25 answers. Go to online appointment … WebLaurikka-Routti. LKT, naistentautien ja synnytysten erikoislääkäri. Asiakasarvio 9.7. 24kk keskiarvo, kun vastauksia yli 25 kpl. Siirry verkkoajanvaraukseen. Marjut Laurikka …

Laurikka-routti

Did you know?

WebInt J Fertil 1976; 21: 103-8. 4. Laurikka-Routti M, Haukkamaa M, Lahteenmaki P. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435. Fertil Steril 1992; 58: 680-9. 5. Croxatto HB, Diaz S. The place of … WebDOI: 10.1016/S0010-7824(01)00294-3 Corpus ID: 8692342; Mechanisms that explain the contraceptive action of progestin implants for women. @article{Croxatto2002MechanismsTE, title={Mechanisms that explain the contraceptive action of progestin implants for women.}, author={Horacio B. Croxatto}, …

Web1 Sep 1991 · Europe PMC is an archive of life sciences journal literature. WebM Laurikka-Routti To study the changes in serum lipids, serum chemistry, blood pressure, and body weight in long-term users of subcutaneous contraceptive implants releasing the …

WebLaurikka-Routti, M., Haukkamaa, M., & Lähteenmäki, P. (1992). Suppression of ovarian-function with the transdermally given synthetic progestin ST 1435. Fertility and Sterility : … WebThe progest in ST 1435, used parenterally for contraception or progestin therapy, had no adverse effects on serum lipids, blood pressure, or body weight, which are known to be risk factors for coronary artery disease. Objective: To study the changes in serum lipids, serum chemistry, blood pressure, and body weight in long-term users of subcutaneous …

WebLaurikka-Routti, M., & Haukkamaa, M. (1992). A contraceptive subdermal implant releasing the progestin ST-1435 - ovarian-function, bleeding patterns, and side-effects. Fertility and …

Web8 Mar 2024 · Naistentautien ja synnytysten erikoislääkäri Marjut Laurikka-Routti sanoo, että kiusallisista vaihdevuosioireista ei kannata kärsiä, koska ne voidaan poistaa hormonihoidolla tehokkaasti. Aamutohtorin aiheena … money heist definitionWebMarjut Laurikka-Routti Naistentautien ja synnytysten erikoislääkäri Näytä vapaat ajat Hinnasto Esittely Hoidan laajalti gynekologisia vaivoja ja asioita: vaihdevuosia, ehkäisyä, … icd 10 code for abusive head traumaWebFinding the cause of the infection requires analyzing certain samples, since the doctor’s eye cannot solely distinguish the cause of the infection, Laurikka-Routti explains. It is … icd 10 code for achromatopsiaWeb1 Dec 1993 · Laurikka-Routti M, Haukkamaa M, Lteenmi P. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435. Fertil Steril 1992; 58: 680-9. 5. Croxatto HB, Diaz S. The place of progesterone in human contraception. J Steroid Biochem 1987; 27: 991-4. 6. Lteenmi PLA, Diaz S, Miranda P, Croxatto HB, Lteenmi P. Milk and ... icd 10 code for achy jointsWeb1 Jan 1992 · Europe PMC is an archive of life sciences journal literature. money heist costume shortsWeb1 Dec 1992 · M. Laurikka-Routti, M. Haukkamaa Published 1 December 1992 Medicine Fertility and sterility View on PubMed doi.org Save to Library Create Alert Cite 17 … icd 10 code for absence of thyroidWeb1 Jul 1990 · M. Laurikka-Routti, M. Haukkamaa, P. Lähteenmäki Medicine 1992 11 PDF A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, … icd 10 code for abscess with cellulitis